Vast is a preclinical biotechnology company focused on treating the world’s most challenging drug-resistant microbial infections that represent one of the greatest threats to global health, food security, and economic development.

Biotechnology

Vast Therapeutics

Vast Therapeutics' headquarters in Durham, NC, United States

Nate Stasko

Mark Schoenfisch

John Simons

Scott Donaldson

Donald Vandevanter

Felix Ratjen

Michael Knowles

John J. Lipuma

Kevin Winthrop

Patrick A. Flume

Chuck Swoboda

The Scientific Advisors and Specialists team at Vast Therapeutics provides expert guidance on research strategies, evaluates scientific data, and advises on the development of innovative therapies to combat drug-resistant microbial infections. They collaborate closely with the Director of Bacteriology and the Principal R&D Scientist to ensure the scientific integrity and efficacy of preclinical projects aimed at addressing global health threats.

Scientific Advisors and Specialists

The Leadership Team at Vast Therapeutics is responsible for setting the strategic direction of the company, guiding product development, and overseeing scientific research initiatives. This team collaborates to ensure the advancement of innovative therapies aimed at combating drug-resistant microbial infections, while fostering a culture of scientific excellence and operational efficiency. Through their combined expertise, they drive the vision to address critical global health challenges.

Vast Therapeutics

Org chart

Board & advisors

Teams

Scientific Advisors and Specialists

Leadership Team

Offices

Vast Therapeutics

Org chart

Board & advisors

Teams

Scientific Advisors and Specialists

Leadership Team

Offices

Related companies